Tuesday, November 22, 2016

Recursion Ups Series A To $15.05M

Salt Lake City-based Recursion Pharmaceuticals announced today that it has raised an additional $2.15M in funding as part of its Series A, bringing the total raised in its round to $15.05M. The additional funding came from individual angels, along with Felicis Ventures. Recursion Pharmaceuticals had previously announced the involvement of Lux Capital, Obvious Ventures, Epic Ventures, Data Collective, AME Cloud Ventures, Wild Basin Investments, and others in the initial tranche.Recursion is developing drug discovery technology for novel drug screening, aimed at identifying pharmaceuticals to treat rare genetic diseases and other conditions. The company has now raised a total of $19M. More information »